Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qiang Ni

Showing results (91-100 of 96) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 96 results.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|July 3, 2026
Patients with hepatitis B virus-related hepatocellular carcinoma underlying cirrhosis have higher microvascular invasion and poorer prognosis after liver resection: A multicenter studyYu Cao, Tian-Chen Zhang, Zhen-Qi Li, et al.
Surgical Endoscopy|February 5, 2026
The impact of microvascular invasion in tumor recurrence and survival after liver resection for non-B non-C hepatocellular carcinoma: a multicenter, propensity score-matched analysisChen Feng, Tian-Chen Zhang, Yu-Ting Wang, et al.
Hepatobiliary Surgery and Nutrition|June 11, 2026
Prediction of postoperative early recurrence and response to adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma with microvascular invasion after hepatectomy: a multicenter studyTian-Chen Zhang, Zhen-Qi Li, Wei-Li Jia, et al.
Molecular Systems Biology|April 4, 2013
Construction of human activity-based phosphorylation networksRobert H Newman, Jianfei Hu, Hee-Sool Rho, et al.
Hepatology International|March 10, 2025
Patterns and outcomes of early and late recurrence after hepatectomy for hepatocellular carcinoma with microvascular invasion: a multicenter study in ChinaXiu-Ping Zhang, Tian-Chen Zhang, Fei-Fan Wu, et al.
Gut|July 3, 2026
Glucagon-like peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors after liver resection for hepatocellular carcinoma in patients with type 2 diabetes: a target trial emulation studyYan-Jun Xiang, Zong-Han Liu, Jin-Kai Feng, et al.
Pageof 10

Showing results (91-100 of 96) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 96 results.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|July 3, 2026
Patients with hepatitis B virus-related hepatocellular carcinoma underlying cirrhosis have higher microvascular invasion and poorer prognosis after liver resection: A multicenter studyYu Cao, Tian-Chen Zhang, Zhen-Qi Li, et al.
Surgical Endoscopy|February 5, 2026
The impact of microvascular invasion in tumor recurrence and survival after liver resection for non-B non-C hepatocellular carcinoma: a multicenter, propensity score-matched analysisChen Feng, Tian-Chen Zhang, Yu-Ting Wang, et al.
Hepatobiliary Surgery and Nutrition|June 11, 2026
Prediction of postoperative early recurrence and response to adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma with microvascular invasion after hepatectomy: a multicenter studyTian-Chen Zhang, Zhen-Qi Li, Wei-Li Jia, et al.
Molecular Systems Biology|April 4, 2013
Construction of human activity-based phosphorylation networksRobert H Newman, Jianfei Hu, Hee-Sool Rho, et al.
Hepatology International|March 10, 2025
Patterns and outcomes of early and late recurrence after hepatectomy for hepatocellular carcinoma with microvascular invasion: a multicenter study in ChinaXiu-Ping Zhang, Tian-Chen Zhang, Fei-Fan Wu, et al.
Gut|July 3, 2026
Glucagon-like peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors after liver resection for hepatocellular carcinoma in patients with type 2 diabetes: a target trial emulation studyYan-Jun Xiang, Zong-Han Liu, Jin-Kai Feng, et al.
Pageof 10